Logo image of AGTI

AGILITI INC (AGTI) Stock Fundamental Analysis

NYSE:AGTI - New York Stock Exchange, Inc. - US00848J1043 - Common Stock - Currency: USD

10.05  -0.05 (-0.5%)

After market: 10.05 0 (0%)

Fundamental Rating

3

Overall AGTI gets a fundamental rating of 3 out of 10. We evaluated AGTI against 103 industry peers in the Health Care Providers & Services industry. AGTI has a medium profitability rating, but doesn't score so well on its financial health evaluation. AGTI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AGTI was profitable.
In the past year AGTI had a positive cash flow from operations.
In multiple years AGTI reported negative net income over the last 5 years.
AGTI had a positive operating cash flow in each of the past 5 years.
AGTI Yearly Net Income VS EBIT VS OCF VS FCFAGTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

1.2 Ratios

AGTI has a Return On Assets of -0.81%. This is comparable to the rest of the industry: AGTI outperforms 52.99% of its industry peers.
Looking at the Return On Equity, with a value of -2.06%, AGTI is in line with its industry, outperforming 56.41% of the companies in the same industry.
AGTI has a Return On Invested Capital of 2.32%. This is comparable to the rest of the industry: AGTI outperforms 50.43% of its industry peers.
AGTI had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 9.71%.
Industry RankSector Rank
ROA -0.81%
ROE -2.06%
ROIC 2.32%
ROA(3y)0.46%
ROA(5y)-0.4%
ROE(3y)1.27%
ROE(5y)-1.8%
ROIC(3y)3.04%
ROIC(5y)N/A
AGTI Yearly ROA, ROE, ROICAGTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

The Operating Margin of AGTI (5.51%) is better than 66.67% of its industry peers.
In the last couple of years the Operating Margin of AGTI has declined.
The Gross Margin of AGTI (34.41%) is better than 62.39% of its industry peers.
AGTI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.51%
PM (TTM) N/A
GM 34.41%
OM growth 3Y5.72%
OM growth 5Y-12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.42%
GM growth 5Y-0.3%
AGTI Yearly Profit, Operating, Gross MarginsAGTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

2

2. Health

2.1 Basic Checks

AGTI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AGTI has more shares outstanding
AGTI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AGTI is higher compared to a year ago.
AGTI Yearly Shares OutstandingAGTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
AGTI Yearly Total Debt VS Total AssetsAGTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

AGTI has an Altman-Z score of 1.19. This is a bad value and indicates that AGTI is not financially healthy and even has some risk of bankruptcy.
AGTI has a Altman-Z score (1.19) which is in line with its industry peers.
AGTI has a debt to FCF ratio of 12.95. This is a negative value and a sign of low solvency as AGTI would need 12.95 years to pay back of all of its debts.
The Debt to FCF ratio of AGTI (12.95) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.13 is on the high side and indicates that AGTI has dependencies on debt financing.
With a Debt to Equity ratio value of 1.13, AGTI is not doing good in the industry: 63.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 12.95
Altman-Z 1.19
ROIC/WACC0.32
WACC7.29%
AGTI Yearly LT Debt VS Equity VS FCFAGTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.72 indicates that AGTI should not have too much problems paying its short term obligations.
AGTI's Current ratio of 1.72 is fine compared to the rest of the industry. AGTI outperforms 64.96% of its industry peers.
A Quick Ratio of 1.34 indicates that AGTI should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.34, AGTI perfoms like the industry average, outperforming 52.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.34
AGTI Yearly Current Assets VS Current LiabilitesAGTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

3

3. Growth

3.1 Past

AGTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.12%.
Looking at the last year, AGTI shows a small growth in Revenue. The Revenue has grown by 4.75% in the last year.
Measured over the past years, AGTI shows a quite strong growth in Revenue. The Revenue has been growing by 15.75% on average per year.
EPS 1Y (TTM)-34.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)4.75%
Revenue growth 3Y14.95%
Revenue growth 5Y15.75%
Sales Q2Q%0.95%

3.2 Future

Based on estimates for the next years, AGTI will show a small growth in Earnings Per Share. The EPS will grow by 4.80% on average per year.
Based on estimates for the next years, AGTI will show a small growth in Revenue. The Revenue will grow by 5.53% on average per year.
EPS Next Y8.01%
EPS Next 2Y7.33%
EPS Next 3Y4.8%
EPS Next 5YN/A
Revenue Next Year4.09%
Revenue Next 2Y4.69%
Revenue Next 3Y5.53%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AGTI Yearly Revenue VS EstimatesAGTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B
AGTI Yearly EPS VS EstimatesAGTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.95, which indicates a rather expensive current valuation of AGTI.
Based on the Price/Earnings ratio, AGTI is valued a bit cheaper than 76.07% of the companies in the same industry.
AGTI is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
AGTI is valuated correctly with a Price/Forward Earnings ratio of 15.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AGTI indicates a somewhat cheap valuation: AGTI is cheaper than 74.36% of the companies listed in the same industry.
AGTI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.95
Fwd PE 15.58
AGTI Price Earnings VS Forward Price EarningsAGTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AGTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AGTI is cheaper than 78.63% of the companies in the same industry.
AGTI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AGTI is cheaper than 82.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.39
EV/EBITDA 10.17
AGTI Per share dataAGTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AGTI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.24
PEG (5Y)N/A
EPS Next 2Y7.33%
EPS Next 3Y4.8%

0

5. Dividend

5.1 Amount

No dividends for AGTI!.
Industry RankSector Rank
Dividend Yield N/A

AGILITI INC

NYSE:AGTI (5/6/2024, 8:04:00 PM)

After market: 10.05 0 (0%)

10.05

-0.05 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2024-05-07/amc
Earnings (Next)08-06 2024-08-06/amc
Inst Owners4.59%
Inst Owner Change-100%
Ins Owners0.26%
Ins Owner Change0%
Market Cap1.37B
Analysts51.67
Price Target10.2 (1.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.61%
Min EPS beat(2)-2.18%
Max EPS beat(2)7.4%
EPS beat(4)2
Avg EPS beat(4)5.03%
Min EPS beat(4)-7.15%
Max EPS beat(4)22.04%
EPS beat(8)5
Avg EPS beat(8)9.4%
EPS beat(12)9
Avg EPS beat(12)51.52%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)1.94%
Revenue beat(4)3
Avg Revenue beat(4)0.54%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)1.94%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)8
Avg Revenue beat(12)0.53%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.05%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)1.35%
EPS NY rev (1m)0%
EPS NY rev (3m)1.92%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE 17.95
Fwd PE 15.58
P/S 1.16
P/FCF 16.39
P/OCF 8.05
P/B 1.45
P/tB N/A
EV/EBITDA 10.17
EPS(TTM)0.56
EY5.57%
EPS(NY)0.65
Fwd EY6.42%
FCF(TTM)0.61
FCFY6.1%
OCF(TTM)1.25
OCFY12.43%
SpS8.64
BVpS6.92
TBVpS-5.36
PEG (NY)2.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.81%
ROE -2.06%
ROCE 2.94%
ROIC 2.32%
ROICexc 2.34%
ROICexgc 9.97%
OM 5.51%
PM (TTM) N/A
GM 34.41%
FCFM 7.1%
ROA(3y)0.46%
ROA(5y)-0.4%
ROE(3y)1.27%
ROE(5y)-1.8%
ROIC(3y)3.04%
ROIC(5y)N/A
ROICexc(3y)3.09%
ROICexc(5y)N/A
ROICexgc(3y)14.42%
ROICexgc(5y)N/A
ROCE(3y)3.85%
ROCE(5y)N/A
ROICexcg growth 3Y3.65%
ROICexcg growth 5Y-11.31%
ROICexc growth 3Y8.13%
ROICexc growth 5Y-21.08%
OM growth 3Y5.72%
OM growth 5Y-12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.42%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 12.95
Debt/EBITDA 4.45
Cap/Depr 49.7%
Cap/Sales 7.36%
Interest Coverage 1.06
Cash Conversion 71.16%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.34
Altman-Z 1.19
F-Score5
WACC7.29%
ROIC/WACC0.32
Cap/Depr(3y)44.33%
Cap/Depr(5y)40.21%
Cap/Sales(3y)7.19%
Cap/Sales(5y)7.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y8.01%
EPS Next 2Y7.33%
EPS Next 3Y4.8%
EPS Next 5YN/A
Revenue 1Y (TTM)4.75%
Revenue growth 3Y14.95%
Revenue growth 5Y15.75%
Sales Q2Q%0.95%
Revenue Next Year4.09%
Revenue Next 2Y4.69%
Revenue Next 3Y5.53%
Revenue Next 5YN/A
EBIT growth 1Y-29.58%
EBIT growth 3Y21.53%
EBIT growth 5Y1.48%
EBIT Next Year245.12%
EBIT Next 3Y57.21%
EBIT Next 5YN/A
FCF growth 1Y-25.75%
FCF growth 3Y2.73%
FCF growth 5Y21.03%
OCF growth 1Y-15.01%
OCF growth 3Y7.63%
OCF growth 5Y14.5%